Candid Therapeutics, Inc, a clinical-stage biotechnology company focused on becoming the leader in advancing T-cell engagers for autoimmune and inflammatory diseases, announced an agreement...
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company from Kyoto University, announced that...
WuXi Biologics ("WuXi Bio") , a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility...
WuXi Biologics, a global Contract Research, Development and Manufacturing Organization (CRDMO) service company, announced that the company received the award for Bioprocessing Excellence in...
WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by...
